...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Proudly Announces Funding for Phase 2 Trial Evaluating Apabetalone in PAH

Here's some more background about the Resverlogix PAH program from a prior post.

New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension

 

Share
New Message
Please login to post a reply